Mereo BioPharma (MREO) Prepaid Assets (2017 - 2026)

Mereo BioPharma (MREO) has reported Prepaid Assets for 10 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets fell 10.72% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (down 10.72% YoY), while the FY2025 annual figure was $2.5 million, up 16.37% from the prior year.
• Prepaid Assets eased to $2.2 million in Q1 2026 per MREO's latest filing, from $2.5 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $5.2 million in Q4 2023 and bottomed at $1.7 million in Q2 2023.
• Historically, Prepaid Assets has averaged $3.1 million across 5 years, with a median of $2.7 million in 2025.
• On a YoY basis, Prepaid Assets climbed as much as 160.7% in 2024 and fell as far as 57.82% in 2024.
• Mereo BioPharma's Prepaid Assets stood at $3.7 million in 2022, then jumped by 40.67% to $5.2 million in 2023, then slumped by 57.82% to $2.2 million in 2024, then gained by 16.37% to $2.5 million in 2025, then dropped by 11.14% to $2.2 million in 2026.
• Business Quant data shows MREO's Prepaid Assets at $2.2 million in Q1 2026, $2.5 million in Q4 2025, and $2.7 million in Q3 2025.